Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.
Aug 2010 - Proc. Natl. Acad. Sci. U.S.A.; 107(31):1091-6490 [PMID:20631300]
[Van Tendeloo VF] [Van de Velde A] [Van Driessche A] [Cools N] [Anguille S] [Ladell K] [Gostick E] [Vermeulen K] [Pieters K] [Nijs G] [Stein B] [Smits EL] [Schroyens WA] [Gadisseur AP] [Vrelust I] [Jorens PG] [Goossens H] [de Vries IJ] [Price DA] [Oji Y] [Oka Y] [Sugiyama H] [Berneman ZN]

Dendritic cell-based cancer gene therapy.
Oct 2009 - Hum. Gene Ther.; 20(10):1557-7422 [PMID:19656053]
[Smits EL] [Anguille S] [Cools N] [Berneman ZN] [Van Tendeloo VF]

Immunotherapy of acute myeloid leukemia: current approaches.
Apr 2009 - Oncologist; 14(3):1549-490X [PMID:19289488]
[Smits EL] [Berneman ZN] [Van Tendeloo VF]

Immunotherapy of hematological malignancies using dendritic cells.
Apr 2008 - Bull Cancer; 95(3):1769-6917 [PMID:18390412]
[Van de Velde AL] [Berneman ZN] [Van Tendeloo VF]

Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells.
Dec 2006 - Mol. Cancer; 5:1476-4598 [PMID:17067378]
[Cools N] [Ponsaerts P] [Lenjou M] [Nijs G] [Van Bockstaele DR] [Van Tendeloo VF] [Berneman ZN]

Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins.
Feb 2006 - Blood; 107(5):0006-4971 [PMID:16263796]
[Van Gulck ER] [Ponsaerts P] [Heyndrickx L] [Vereecken K] [Moerman F] [De Roo A] [Colebunders R] [Van den Bosch G] [Van Bockstaele DR] [Van Tendeloo VF] [Allard S] [Verrier B] [Marañón C] [Hoeffel G] [Hosmalin A] [Berneman ZN] [Vanham G]